Notice of Public Comment Period on Technical Documents for External Peer Review and the Pool of Candidate Peer Reviewers for a Report on Physiologically Based Pharmacokinetic (PBPK) Modeling for Chloroprene and a Supplemental Analysis of Metabolite Clearance, 44885-44887 [2020-16048]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices Comments Due: 5 p.m. ET 8/7/20. Docket Numbers: ER20–2456–000. Applicants: Mid-Atlantic Interstate Transmission, LLC, PJM Interconnection, L.L.C. Description: Section 205(d) Rate Filing: Mid-Atlantic Interstate Transmision submits IA SA No. 5657 to be effective 9/20/2020. Filed Date: 7/20/20. Accession Number: 20200720–5065. Comments Due: 5 p.m. ET 8/10/20. Docket Numbers: ER20–2457–000. Applicants: PJM Interconnection, L.L.C. Description: Section 205(d) Rate Filing: Original ISA, Service Agreement No. 5679; Queue No. AF1–189 to be effective 6/18/2020. Filed Date: 7/20/20. Accession Number: 20200720–5070. Comments Due: 5 p.m. ET 8/10/20. Docket Numbers: ER20–2458–000. Applicants: Hunter Solar LLC. Description: Baseline eTariff Filing: Application for Market-Based Rate Authority to be effective 9/19/2020. Filed Date: 7/20/20. Accession Number: 20200720–5084. Comments Due: 5 p.m. ET 8/10/20. Docket Numbers: ER20–2459–000. Applicants: Tri-State Generation and Transmission Association, Inc. Description: Tariff Cancellation: Notice of Cancellation of Service Agreement No. 850 to be effective 9/1/ 2020. Filed Date: 7/20/20. Accession Number: 20200720–5088. Comments Due: 5 p.m. ET 8/10/20. Docket Numbers: ER20–2460–000. Applicants: Tri-State Generation and Transmission Association, Inc. Description: Section 205(d) Rate Filing: Amendment to Tri-State Rate Schedule No. 100 to be effective 2/26/ 2020. Filed Date: 7/20/20. Accession Number: 20200720–5111. Comments Due: 5 p.m. ET 8/10/20. Docket Numbers: ER20–2461–000. Applicants: PJM Interconnection, L.L.C. Description: Section 205(d) Rate Filing: Amendment to ISA, SA No. 5633; Queue No. AC2–088/AD1–136 (amend) to be effective 4/9/2020. Filed Date: 7/20/20. Accession Number: 20200720–5112. Comments Due: 5 p.m. ET 8/10/20. The filings are accessible in the Commission’s eLibrary system (https:// elibrary.ferc.gov/idmws/search/ fercgensearch.asp) by querying the docket number. Any person desiring to intervene or protest in any of the above proceedings VerDate Sep<11>2014 20:45 Jul 23, 2020 Jkt 250001 must file in accordance with Rules 211 and 214 of the Commission’s Regulations (18 CFR 385.211 and 385.214) on or before 5:00 p.m. Eastern time on the specified comment date. Protests may be considered, but intervention is necessary to become a party to the proceeding. eFiling is encouraged. More detailed information relating to filing requirements, interventions, protests, service, and qualifying facilities filings can be found at: https://www.ferc.gov/ docs-filing/efiling/filing-req.pdf. For other information, call (866) 208–3676 (toll free). For TTY, call (202) 502–8659. Dated: July 20, 2020. Nathaniel J. Davis, Sr., Deputy Secretary. [FR Doc. 2020–16082 Filed 7–23–20; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. ER20–2448–000] American Kings Solar, LLC; Supplemental Notice That Initial Market-Based Rate Filing Includes Request for Blanket Section 204 Authorization This is a supplemental notice in the above-referenced proceeding of American Kings Solar, LLC’s application for market-based rate authority, with an accompanying rate tariff, noting that such application includes a request for blanket authorization, under 18 CFR part 34, of future issuances of securities and assumptions of liability. Any person desiring to intervene or to protest should file with the Federal Energy Regulatory Commission, 888 First Street NE, Washington, DC 20426, in accordance with Rules 211 and 214 of the Commission’s Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone filing a motion to intervene or protest must serve a copy of that document on the Applicant. Notice is hereby given that the deadline for filing protests with regard to the applicant’s request for blanket authorization, under 18 CFR part 34, of future issuances of securities and assumptions of liability, is August 10, 2020. The Commission encourages electronic submission of protests and interventions in lieu of paper, using the FERC Online links at https:// www.ferc.gov. To facilitate electronic service, persons with internet access PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 44885 who will eFile a document and/or be listed as a contact for an intervenor must create and validate an eRegistration account using the eRegistration link. Select the eFiling link to log on and submit the intervention or protests. Persons unable to file electronically may mail similar pleadings to the Federal Energy Regulatory Commission, 888 First Street, NE Washington, DC 20426. Hand delivered submissions in docketed proceedings should be delivered to Health and Human Services, 12225 Wilkins Avenue, Rockville, Maryland 20852. In addition to publishing the full text of this document in the Federal Register, the Commission provides all interested persons an opportunity to view and/or print the contents of this document via the internet through the Commission’s Home Page (https:// ferc.gov) using the ‘‘eLibrary’’ link. Enter the docket number excluding the last three digits in the docket number field to access the document. At this time, the Commission has suspended access to the Commission’s Public Reference Room, due to the proclamation declaring a National Emergency concerning the Novel Coronavirus Disease (COVID–19), issued by the President on March 13, 2020. For assistance, contact the Federal Energy Regulatory Commission at FERCOnlineSupport@ferc.gov or call toll-free, (886) 208–3676 or TYY, (202) 502–8659. Dated: July 20, 2020. Nathaniel J. Davis, Sr., Deputy Secretary. [FR Doc. 2020–16078 Filed 7–23–20; 8:45 am] BILLING CODE 6717–01–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–ORD–2020–0181; FRL–10011–36– ORD] Notice of Public Comment Period on Technical Documents for External Peer Review and the Pool of Candidate Peer Reviewers for a Report on Physiologically Based Pharmacokinetic (PBPK) Modeling for Chloroprene and a Supplemental Analysis of Metabolite Clearance Environmental Protection Agency (EPA). ACTION: Notice of public comment period and external peer review. AGENCY: The Environmental Protection Agency (EPA) is announcing a 30-day public comment period on documents SUMMARY: E:\FR\FM\24JYN1.SGM 24JYN1 jbell on DSKJLSW7X2PROD with NOTICES 44886 Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices associated with a Report on Physiologically Based Pharmacokinetic (PBPK) Modeling for Chloroprene and a Supplemental Analysis of Metabolite Clearance. These documents will undergo independent external scientific peer review managed by Versar (https:// www.versar.com/), an EPA contractor. Public comments on the documents associated with the PBPK modeling will be provided to the external peer reviewers. Versar will convene a virtual meeting of the peer reviewers, which will be open to the public and include an opportunity to provide oral comments. In preparation for the external peer review, EPA is also announcing a 30-day public comment period on the pool of candidates to conduct the external peer review of the documents identified above. Versar will consider public comments on these candidates and evaluate any conflicts of interest and/or appearance of lack of impartiality, and will then select nine independent experts from the pool of 19 candidates. Information on the external peer review process, including details on how to provide comments on the proposed pool of candidates, is further described in this notice. Once complete, the final peer review report will be used to inform EPA’s Reconsideration of a 2017 Request for Correction related to the Integrated Risk Information System (IRIS) assessment of chloroprene. DATES: The 30-day public comment period on the technical documents and the list of proposed peer review candidates begins July 24, 2020 and ends August 24, 2020. Comments must be received on or before August 24, 2020. ADDRESSES: Submit written comments to Docket ID No. EPA–HQ–ORD–2020– 0181 no later than August 24, 2020. Documents associated with this peer review will be available within the docket. Submit comments on the pool of candidate peer reviewers to Versar no later than August 24, 2020 by one of the following methods: chloroprenePBPK@ versar.com (Subject line: Chloroprene PBPK Peer Review); or by phone (301) 304–3121 (ask for Tracey Cowen). Please be advised that public comments are subject to release under the Freedom of Information Act. FOR FURTHER INFORMATION CONTACT: For information on how to submit comments on the technical documents contact: The EPA Headquarters Docket Center; telephone: 202–566–1752; facsimile: 202–566–9744; or email: Docket_ORD@epa.gov. For general information contact: Dahnish Shams, CPHEA; telephone: VerDate Sep<11>2014 20:45 Jul 23, 2020 Jkt 250001 202–564–2758; or email: shams.dahnish@epa.gov. For information regarding the peer review contact: Versar at chloroprenePBPK@versar.com (Subject line: Chloroprene PBPK Peer Review); or by phone (301) 304–3121 (ask for Tracey Cowen). SUPPLEMENTARY INFORMATION: I. Background On June 26, 2017, the U.S. EPA received a Request for Correction (RFC) provided on behalf of Denka Performance Elastomer LLC (DPE). In the RFC letter, DPE claimed that the Toxicological Review of Chloroprene (CAS NO. 126–99–8) in Support of Summary Information on the Integrated Risk Information System (IRIS), disseminated by EPA’s Office of Research and Development (ORD) in 2010, did not reflect the ‘‘best available science’’ or ‘‘sound and objective scientific practices’’ and requested correction. On January 25, 2018, EPA concluded in response that the underlying information and conclusions presented in the IRIS chloroprene assessment are consistent with the EPA’s Information Quality Guidelines and that no evidence published since the 2010 IRIS Assessment would change its conclusions. On July 23, 2018, DPE submitted a Request for Reconsideration of Denial of Request for Correction (RFR) with regard to EPA’s decision, and entered into discussions with EPA to address the uncertainties identified by EPA as documented in the RFC response. Additional information regarding the chloroprene RFC/RFR can be found at: https://www.epa.gov/ quality/epa-information-qualityguidelines-requests-correction-andrequests-reconsideration#17002. Discussions with Denka LLC (DPE) and its contractor, Ramboll, are summarized on the IRIS website (https:// cfpub.epa.gov/ncea/iris2/events.cfm# stakeholderMeetings). An updated PBPK model is now available in a report: ‘‘Physiologically Based Pharmacokinetic (PBPK) Modeling for Chloroprene (Ramboll, 2020)’’. This report, and a Supplemental Analysis of Metabolite Clearance (U.S. EPA, 2020), will undergo external peer review to help to inform future decisions regarding the RFR. II. Information About this Peer Review Versar is considering a list of candidates from which to select the independent, external, peer review panel. The List of Candidates (LoC) document has been posted to the docket at https://www.regulations.gov (Docket ID No. EPA–HQ–ORD–2020–0181) and PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 is included below. After review and consideration of public comments, Versar will select from this pool the final list of nine (9) peer reviewers in a manner consistent with EPA’s Peer Review Handbook 4th Edition, 2015 (EPA/100/B–15/001). Versar will independently conduct a conflict of interest (COI) screening of candidates to ensure that the selected experts have no COI. EPA will announce the peer review panel meeting date, location, and registration details, along with the final list of peer reviewers selected by Versar, at least 30 days prior to the peer review meeting, on the EPA IRIS website (https://www.epa.gov/iris). Teleconference and webinar information regarding this public meeting will be provided through the IRIS website (https://www.epa.gov/iris) and via EPA’s IRIS listserv. To register for the IRIS listserv, visit IRIS website at https://www.epa.gov/iris/forms/ staying-connected-integrated-riskinformation-system#connect. Specific questions or comments on the peer review process should be directed to Versar by email: chloroprenePBPK@ versar.com (Subject line: Chloroprene PBPK Peer Review); or by phone (301) 304–3121 (ask for Tracey Cowen). Comments or questions regarding the peer review candidates must be provided to Versar by August 24, 2020. 1. Guohua An, M.D., Ph.D., Iowa State University 2. Leslie Z. Benet, Ph.D., University of California San Francisco 3. James V. Bruckner, Ph.D., University of Georgia 4. Michael J. Daniels, Ph.D., University of Florida 5. Stephen S. Ferguson, Ph.D., National Institute of Environmental Health Sciences (NIEHS), National Toxicology Program Division (DNTP) 6. Bernard T. Golding, Ph.D., Newcastle University, UK 7. Jeffrey Heys, Ph.D., P.E., Montana State University 8. Nan-Hung Hsieh, Ph.D., Texas A&M University 9. Zhoumeng Lin, BMed, Ph.D., D.A.B.T., Kansas State University 10. Jochem Louisse, Ph.D., Wageningen Food Safety Research (WFSR), part of Wageningen University and Research, the Netherlands 11. Annie Lumen, Ph.D., Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR) 12. Kenneth M. Portier, Ph.D., Independent Consultant 13. Dhaval K. Shah, Ph.D., University of Buffalo 14. Kan Shao, Ph.D., Indiana University 15. Jordan Ned Smith, Ph.D., Pacific Northwest National Laboratory (PNNL) E:\FR\FM\24JYN1.SGM 24JYN1 Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices 16. Gong Tang, Ph.D., University of Pittsburgh, Graduate School of Public Health 17. Raymond S. H. Yang, Ph.D., Colorado State University 18. Qiang Zhang, Ph.D., Emory University 19. Yiliang Zhu, Ph.D., University of New Mexico School of Medicine III. How to Submit Technical Comments to the Docket Please note that questions or comments regarding the peer review process, including comments on the candidate pool of peer reviewers, should be directed to chloroprenePBPK@versar.com (Subject line: Chloroprene PBPK Peer Review); or by phone (301) 304–3121 (ask for Tracey Cowen). Comments on the technical documents related to the PBPK modeling should be submitted to Docket ID No. EPA–HQ–ORD–2020– 0181, by one of the following methods: • Online: https:// www.regulations.gov. Follow the online instructions for submitting comments. • Email: Docket_ORD@epa.gov. • Fax: 202–566–9744. Due to COVID– 19, there may be a delay in processing comments submitted by fax. • Mail: U.S. Environmental Protection Agency, EPA Docket Center (ORD Docket), Mail Code: 28221T, 1200 Pennsylvania Avenue NW, Washington, DC 20460. The phone number is 202– 566–1752. Due to COVID–19, there may be a delay in processing comments submitted by mail. jbell on DSKJLSW7X2PROD with NOTICES Note: The EPA Docket Center and Reading Room is currently closed to public visitors to reduce the risk of transmitting COVID–19. Docket Center staff will continue to provide remote customer service via email, phone, and webform. The public can submit comments via www.Regulations.gov or email. No hand deliveries are currently being accepted. Instructions: Direct your comments to Docket ID No. EPA–HQ–ORD–2020– 0181. Please ensure that your comments are submitted within the specified comment period. Comments received after the closing date will be marked ‘‘late,’’ and may only be considered if time permits. It is EPA’s policy to include all comments it receives in the public docket without change and to make the comments available online at www.regulations.gov, including any personal information provided, unless a comment includes information claimed to be Confidential Business Information (CBI) or other information for which disclosure is restricted by statute. Do not submit information through www.regulations.gov or email that you consider to be CBI or otherwise protected. The www.regulations.gov website is an ‘‘anonymous access’’ VerDate Sep<11>2014 20:45 Jul 23, 2020 Jkt 250001 system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an email comment directly to EPA without going through www.regulations.gov, your email address will be automatically captured and included as part of the comment that is placed in the public docket and made available on the internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD–ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. For additional information about EPA’s public docket visit the EPA Docket Center homepage at www.epa.gov/epahome/dockets.htm. Docket: Documents in the docket are listed in the www.regulations.gov index. Although listed in the index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other materials, such as copyrighted material, are publicly available only in hard copy. Publicly available docket materials are available either electronically in www.regulations.gov or in hard copy at the ORD Docket in the EPA Headquarters Docket Center. Wayne E. Cascio, Director, Center for Public Health & Environmental Assessment. [FR Doc. 2020–16048 Filed 7–23–20; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–ORD–2020–0183; FRL–10012–20– ORD] Availability of the IRIS Assessment Plan for Oral Exposure to Vanadium and Compounds Environmental Protection Agency (EPA). ACTION: Notice of public comment period. AGENCY: The Environmental Protection Agency (EPA) is announcing a 30-day public comment period associated with release of the IRIS Assessment Plan for Oral Exposure to Vanadium and Compounds. This document communicates information on the SUMMARY: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 44887 scoping needs identified by EPA program and regional offices and the IRIS Program’s initial problem formulation activities. Specifically, the assessment plan outlines the objectives for the IRIS assessment and the type of evidence considered most pertinent to address the scoping needs. EPA is releasing this IRIS Assessment Plan for a 30-day public comment period in advance of a public science webinar planned for August 19, 2020. The Agency encourages the public to comment on all aspects of the assessment plan, including key science issues and identification of any new or missing studies. DATES: The 30-day public comment period begins July 24, 2020 and ends August 24, 2020. Comments must be received on or before August 24, 2020. ADDRESSES: The IRIS Assessment Plan for Oral Exposure to Vanadium and Compounds will be available via the internet on the IRIS website at https:// www.epa.gov/iris/iris-recent-additions and in the public docket at https:// www.regulations.gov, Docket ID No. EPA–HQ–ORD–2020–0182. FOR FURTHER INFORMATION CONTACT: For information on the public comment period, contact the ORD Docket at the EPA Headquarters Docket Center; telephone: 202–566–1752; facsimile: 202–566–9744; or email:Docket_ORD@ epa.gov. For technical information on the IRIS Assessment Plan for Oral Exposure to Vanadium and Compounds, contact Dr. James Avery, CPHEA; telephone: 202– 564–1494; or email: avery.james@ epa.gov. SUPPLEMENTARY INFORMATION: I. Information About IRIS Assessment Plans EPA’s IRIS Program is a human health assessment program that evaluates quantitative and qualitative information on the health effects that may result from exposure to chemicals found in the environment. Through the IRIS Program, EPA provides high quality science-based human health assessments to support the Agency’s regulatory activities and decisions to protect public health. As part of scoping and initial problem formulation activities prior to the development of an assessment, the IRIS Program carries out a broad, preliminary literature survey to assist in identifying health effects that have been studied in relation to the chemical or substance of interest, as well as science issues that may need to be considered when evaluating toxicity. This information, in conjunction with scoping needs identified by EPA E:\FR\FM\24JYN1.SGM 24JYN1

Agencies

[Federal Register Volume 85, Number 143 (Friday, July 24, 2020)]
[Notices]
[Pages 44885-44887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16048]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-ORD-2020-0181; FRL-10011-36-ORD]


Notice of Public Comment Period on Technical Documents for 
External Peer Review and the Pool of Candidate Peer Reviewers for a 
Report on Physiologically Based Pharmacokinetic (PBPK) Modeling for 
Chloroprene and a Supplemental Analysis of Metabolite Clearance

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of public comment period and external peer review.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is announcing a 30-
day public comment period on documents

[[Page 44886]]

associated with a Report on Physiologically Based Pharmacokinetic 
(PBPK) Modeling for Chloroprene and a Supplemental Analysis of 
Metabolite Clearance. These documents will undergo independent external 
scientific peer review managed by Versar (https://www.versar.com/), an 
EPA contractor. Public comments on the documents associated with the 
PBPK modeling will be provided to the external peer reviewers. Versar 
will convene a virtual meeting of the peer reviewers, which will be 
open to the public and include an opportunity to provide oral comments. 
In preparation for the external peer review, EPA is also announcing a 
30-day public comment period on the pool of candidates to conduct the 
external peer review of the documents identified above. Versar will 
consider public comments on these candidates and evaluate any conflicts 
of interest and/or appearance of lack of impartiality, and will then 
select nine independent experts from the pool of 19 candidates. 
Information on the external peer review process, including details on 
how to provide comments on the proposed pool of candidates, is further 
described in this notice. Once complete, the final peer review report 
will be used to inform EPA's Reconsideration of a 2017 Request for 
Correction related to the Integrated Risk Information System (IRIS) 
assessment of chloroprene.

DATES: The 30-day public comment period on the technical documents and 
the list of proposed peer review candidates begins July 24, 2020 and 
ends August 24, 2020. Comments must be received on or before August 24, 
2020.

ADDRESSES: Submit written comments to Docket ID No. EPA-HQ-ORD-2020-
0181 no later than August 24, 2020. Documents associated with this peer 
review will be available within the docket.
    Submit comments on the pool of candidate peer reviewers to Versar 
no later than August 24, 2020 by one of the following methods: 
[email protected] (Subject line: Chloroprene PBPK Peer 
Review); or by phone (301) 304-3121 (ask for Tracey Cowen). Please be 
advised that public comments are subject to release under the Freedom 
of Information Act.

FOR FURTHER INFORMATION CONTACT: 
    For information on how to submit comments on the technical 
documents contact: The EPA Headquarters Docket Center; telephone: 202-
566-1752; facsimile: 202-566-9744; or email: [email protected].
    For general information contact: Dahnish Shams, CPHEA; telephone: 
202-564-2758; or email: [email protected].
    For information regarding the peer review contact: Versar at 
[email protected] (Subject line: Chloroprene PBPK Peer 
Review); or by phone (301) 304-3121 (ask for Tracey Cowen).

SUPPLEMENTARY INFORMATION:

I. Background

    On June 26, 2017, the U.S. EPA received a Request for Correction 
(RFC) provided on behalf of Denka Performance Elastomer LLC (DPE). In 
the RFC letter, DPE claimed that the Toxicological Review of 
Chloroprene (CAS NO. 126-99-8) in Support of Summary Information on the 
Integrated Risk Information System (IRIS), disseminated by EPA's Office 
of Research and Development (ORD) in 2010, did not reflect the ``best 
available science'' or ``sound and objective scientific practices'' and 
requested correction. On January 25, 2018, EPA concluded in response 
that the underlying information and conclusions presented in the IRIS 
chloroprene assessment are consistent with the EPA's Information 
Quality Guidelines and that no evidence published since the 2010 IRIS 
Assessment would change its conclusions. On July 23, 2018, DPE 
submitted a Request for Reconsideration of Denial of Request for 
Correction (RFR) with regard to EPA's decision, and entered into 
discussions with EPA to address the uncertainties identified by EPA as 
documented in the RFC response. Additional information regarding the 
chloroprene RFC/RFR can be found at: https://www.epa.gov/quality/epa-information-quality-guidelines-requests-correction-and-requests-reconsideration#17002. Discussions with Denka LLC (DPE) and its 
contractor, Ramboll, are summarized on the IRIS website (https://cfpub.epa.gov/ncea/iris2/events.cfm#stakeholderMeetings).
    An updated PBPK model is now available in a report: 
``Physiologically Based Pharmacokinetic (PBPK) Modeling for Chloroprene 
(Ramboll, 2020)''. This report, and a Supplemental Analysis of 
Metabolite Clearance (U.S. EPA, 2020), will undergo external peer 
review to help to inform future decisions regarding the RFR.

II. Information About this Peer Review

    Versar is considering a list of candidates from which to select the 
independent, external, peer review panel. The List of Candidates (LoC) 
document has been posted to the docket at https://www.regulations.gov 
(Docket ID No. EPA-HQ-ORD-2020-0181) and is included below. After 
review and consideration of public comments, Versar will select from 
this pool the final list of nine (9) peer reviewers in a manner 
consistent with EPA's Peer Review Handbook 4th Edition, 2015 (EPA/100/
B-15/001). Versar will independently conduct a conflict of interest 
(COI) screening of candidates to ensure that the selected experts have 
no COI. EPA will announce the peer review panel meeting date, location, 
and registration details, along with the final list of peer reviewers 
selected by Versar, at least 30 days prior to the peer review meeting, 
on the EPA IRIS website (https://www.epa.gov/iris). Teleconference and 
webinar information regarding this public meeting will be provided 
through the IRIS website (https://www.epa.gov/iris) and via EPA's IRIS 
listserv. To register for the IRIS listserv, visit IRIS website at 
https://www.epa.gov/iris/forms/staying-connected-integrated-risk-information-system#connect. Specific questions or comments on the peer 
review process should be directed to Versar by email: 
[email protected] (Subject line: Chloroprene PBPK Peer 
Review); or by phone (301) 304-3121 (ask for Tracey Cowen). Comments or 
questions regarding the peer review candidates must be provided to 
Versar by August 24, 2020.

1. Guohua An, M.D., Ph.D., Iowa State University
2. Leslie Z. Benet, Ph.D., University of California San Francisco
3. James V. Bruckner, Ph.D., University of Georgia
4. Michael J. Daniels, Ph.D., University of Florida
5. Stephen S. Ferguson, Ph.D., National Institute of Environmental 
Health Sciences (NIEHS),
    National Toxicology Program Division (DNTP)
6. Bernard T. Golding, Ph.D., Newcastle University, UK
7. Jeffrey Heys, Ph.D., P.E., Montana State University
8. Nan-Hung Hsieh, Ph.D., Texas A&M University
9. Zhoumeng Lin, BMed, Ph.D., D.A.B.T., Kansas State University
10. Jochem Louisse, Ph.D., Wageningen Food Safety Research (WFSR), 
part of Wageningen University and Research, the Netherlands
11. Annie Lumen, Ph.D., Food and Drug Administration (FDA), National 
Center for Toxicological Research (NCTR)
12. Kenneth M. Portier, Ph.D., Independent Consultant
13. Dhaval K. Shah, Ph.D., University of Buffalo
14. Kan Shao, Ph.D., Indiana University
15. Jordan Ned Smith, Ph.D., Pacific Northwest National Laboratory 
(PNNL)

[[Page 44887]]

16. Gong Tang, Ph.D., University of Pittsburgh, Graduate School of 
Public Health
17. Raymond S. H. Yang, Ph.D., Colorado State University
18. Qiang Zhang, Ph.D., Emory University
19. Yiliang Zhu, Ph.D., University of New Mexico School of Medicine

III. How to Submit Technical Comments to the Docket

    Please note that questions or comments regarding the peer review 
process, including comments on the candidate pool of peer reviewers, 
should be directed to [email protected] (Subject line: 
Chloroprene PBPK Peer Review); or by phone (301) 304-3121 (ask for 
Tracey Cowen). Comments on the technical documents related to the PBPK 
modeling should be submitted to Docket ID No. EPA-HQ-ORD-2020-0181, by 
one of the following methods:
     Online: https://www.regulations.gov. Follow the online 
instructions for submitting comments.
     Email: [email protected].
     Fax: 202-566-9744. Due to COVID-19, there may be a delay 
in processing comments submitted by fax.
     Mail: U.S. Environmental Protection Agency, EPA Docket 
Center (ORD Docket), Mail Code: 28221T, 1200 Pennsylvania Avenue NW, 
Washington, DC 20460. The phone number is 202-566-1752. Due to COVID-
19, there may be a delay in processing comments submitted by mail.

    Note: The EPA Docket Center and Reading Room is currently closed 
to public visitors to reduce the risk of transmitting COVID-19. 
Docket Center staff will continue to provide remote customer service 
via email, phone, and webform. The public can submit comments via 
www.Regulations.gov or email. No hand deliveries are currently being 
accepted.

    Instructions: Direct your comments to Docket ID No. EPA-HQ-ORD-
2020-0181. Please ensure that your comments are submitted within the 
specified comment period. Comments received after the closing date will 
be marked ``late,'' and may only be considered if time permits. It is 
EPA's policy to include all comments it receives in the public docket 
without change and to make the comments available online at 
www.regulations.gov, including any personal information provided, 
unless a comment includes information claimed to be Confidential 
Business Information (CBI) or other information for which disclosure is 
restricted by statute. Do not submit information through 
www.regulations.gov or email that you consider to be CBI or otherwise 
protected. The www.regulations.gov website is an ``anonymous access'' 
system, which means EPA will not know your identity or contact 
information unless you provide it in the body of your comment. If you 
send an email comment directly to EPA without going through 
www.regulations.gov, your email address will be automatically captured 
and included as part of the comment that is placed in the public docket 
and made available on the internet. If you submit an electronic 
comment, EPA recommends that you include your name and other contact 
information in the body of your comment and with any disk or CD-ROM you 
submit. If EPA cannot read your comment due to technical difficulties 
and cannot contact you for clarification, EPA may not be able to 
consider your comment. Electronic files should avoid the use of special 
characters, any form of encryption, and be free of any defects or 
viruses. For additional information about EPA's public docket visit the 
EPA Docket Center homepage at www.epa.gov/epahome/dockets.htm.
    Docket: Documents in the docket are listed in the 
www.regulations.gov index. Although listed in the index, some 
information is not publicly available, e.g., CBI or other information 
whose disclosure is restricted by statute. Certain other materials, 
such as copyrighted material, are publicly available only in hard copy. 
Publicly available docket materials are available either electronically 
in www.regulations.gov or in hard copy at the ORD Docket in the EPA 
Headquarters Docket Center.

Wayne E. Cascio,
Director, Center for Public Health & Environmental Assessment.
[FR Doc. 2020-16048 Filed 7-23-20; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.